ITGAX and neoplasm: IL-2/CD40 slowed tumor growth in both age groups (completely in young, partially in elderly) and this may be explained by our observations that IL-2/CD40 induced several common effects on tumor-infiltrating CD11c+ cells, CD8+ T cells, and CD4+ T cells from both age groups.